Loading…

Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice

Saved in:

Bibliographic Details
Published in:	British journal of dermatology (1951) 2022-04, Vol.186 (4), p.733-735
Main Authors:	Marniquet, M.‐E., Seneschal, J., Darrigade, A.‐S., Staumont‐Sallé, D., Jachiet, M., Nosbaum, A., Tauber, M., Abasq, C., Ferrier Le Bouedec, M.‐C., Droitcourt, C., Aubert, H., Bernier, C., Soria, A., Raison‐Peyron, N., Tétart, F., Aubin, F., Viguier, M., Valois, A., Kupfer‐Bessaguet, I., Goronflot, T., Barbarot, S.
Format:	Article
Language:	English
Subjects:	Adult Antibodies, Monoclonal, Humanized - adverse effects Atopic dermatitis Dermatitis, Atopic - drug therapy Eczema Humans Life Sciences Monoclonal antibodies Severity of Illness Index Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!